Oklahoma — Oklahoma City, Oklahoma

Oklahoma is a clinical research site located in Oklahoma City, Oklahoma, United States.

Crixeo Health Trust Score: 50/100 (POOR). This profile has not yet been claimed by the site owner.

Oklahoma has participated in 2 clinical trials.

Therapeutic areas: Epilepsy, Locally Advanced Cancer, Metastatic Cancer.

Sponsors: Vertex Pharmaceuticals Incorporated, OncoMed Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 50/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oklahoma?

Oklahoma has a Crixeo Trust Score of 50/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oklahoma conducted?

Oklahoma has 2 clinical trials on record. Their work covers Epilepsy, Locally Advanced Cancer, Metastatic Cancer.

Is Oklahoma accredited by Crixeo Health?

Oklahoma has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oklahoma?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.